timolol has been researched along with Cardiac Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolobe, OMP | 1 |
| Can, B; Cicek, FA; Toy, A; Tuncay, E; Turan, B | 1 |
| Ardell, JL; Girasole, AE; Hardwick, JC; Negrotto, S; Ryan, SE; Southerland, EM | 1 |
| Borer, JS; Moses, JW | 1 |
| Caprioli, J; Sears, ML | 1 |
| Collignon, P | 1 |
| Arrowsmith, JB; Fraunfelder, FT; Kuritsky, JN; Nelson, WL; Sills, JM | 1 |
| Johannessen, KA; Nordrehaug, JE; von der Lippe, G | 1 |
| Harrison, DC | 1 |
1 review(s) available for timolol and Cardiac Diseases
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
1 trial(s) available for timolol and Cardiac Diseases
| Article | Year |
|---|---|
Increased occurrence of left ventricular thrombi during early treatment with timolol in patients with acute myocardial infarction.
Topics: Creatine Kinase; Double-Blind Method; Drug Evaluation; Echocardiography; Heart Diseases; Heart Ventricles; Humans; Myocardial Infarction; Random Allocation; Systole; Thrombosis; Time Factors; Timolol; Warfarin | 1987 |
8 other study(ies) available for timolol and Cardiac Diseases
| Article | Year |
|---|---|
Cardiac and extracardiac side effects of eye drops.
Topics: Adrenergic beta-Antagonists; Atropine; Bradycardia; Carteolol; Female; Heart Diseases; Humans; Ophthalmic Solutions; Timolol; Verapamil | 2021 |
Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Disease Models, Animal; Endoplasmic Reticulum Stress; Heart Diseases; Hyperglycemia; Male; Oxidative Stress; Rats; Rats, Wistar; Timolol | 2014 |
Remodeling of intrinsic cardiac neurons: effects of β-adrenergic receptor blockade in guinea pig models of chronic heart disease.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Cholinergic Agents; Chronic Disease; Disease Models, Animal; Evoked Potentials; Guinea Pigs; Heart; Heart Diseases; Male; Myocardial Infarction; Neurons; Receptors, Adrenergic, beta; Timolol | 2012 |
Caution on the preoperative use of topical timolol.
Topics: Administration, Topical; Heart Diseases; Humans; Preoperative Care; Propanolamines; Timolol | 1983 |
What's new in drugs.
Topics: Catecholamines; Dobutamine; Glaucoma; Heart Diseases; Humans; Propanolamines; Timolol | 1979 |
Cardiovascular and pulmonary effects of beta-blocking agents: implications for their use in ophthalmology.
Topics: Adrenergic beta-Antagonists; Age Factors; Betaxolol; Cardiovascular System; Drug Interactions; Glaucoma; Heart Diseases; Heart Rate; Humans; Intraocular Pressure; Lung; Lung Diseases; Propanolamines; Timolol | 1989 |
Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.
Topics: Heart Diseases; Humans; Mortality; Respiration Disorders; Timolol | 1986 |
Cost containment in medicine: why cardiology?
Topics: Cardiology; Coronary Artery Bypass; Coronary Care Units; Cost Control; Cost-Benefit Analysis; Costs and Cost Analysis; Diagnosis-Related Groups; Heart Diseases; Humans; Myocardial Infarction; Timolol; United States | 1985 |